- Home
- ABVC vs MYO Comparison
ABVC vs MYO Comparison
Compare ABVC & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABVC
- MYO
- Stock Information
- Founded
- ABVC 2015
- MYO 2004
- Country
- ABVC United States
- MYO United States
- Employees
- ABVC N/A
- MYO N/A
- Industry
- ABVC Biotechnology: Pharmaceutical Preparations
- MYO Industrial Specialties
- Sector
- ABVC Health Care
- MYO Health Care
- Exchange
- ABVC Nasdaq
- MYO Nasdaq
- Market Cap
- ABVC 52.1M
- MYO 44.6M
- IPO Year
- ABVC N/A
- MYO 2017
- Fundamental
- Price
- ABVC $2.72
- MYO $0.86
- Analyst Decision
- ABVC
- MYO Strong Buy
- Analyst Count
- ABVC 0
- MYO 3
- Target Price
- ABVC N/A
- MYO $8.17
- AVG Volume (30 Days)
- ABVC 82.8K
- MYO 1.4M
- Earning Date
- ABVC 11-13-2025
- MYO 11-05-2025
- Dividend Yield
- ABVC N/A
- MYO N/A
- EPS Growth
- ABVC N/A
- MYO N/A
- EPS
- ABVC N/A
- MYO N/A
- Revenue
- ABVC $391,242.00
- MYO $40,760,091.00
- Revenue This Year
- ABVC $735.18
- MYO $25.69
- Revenue Next Year
- ABVC N/A
- MYO $23.52
- P/E Ratio
- ABVC N/A
- MYO N/A
- Revenue Growth
- ABVC 186.84
- MYO 93.08
- 52 Week Low
- ABVC $0.40
- MYO $0.80
- 52 Week High
- ABVC $5.48
- MYO $7.17
- Technical
- Relative Strength Index (RSI)
- ABVC 45.18
- MYO 28.17
- Support Level
- ABVC $2.64
- MYO $0.80
- Resistance Level
- ABVC $2.90
- MYO $0.90
- Average True Range (ATR)
- ABVC 0.16
- MYO 0.07
- MACD
- ABVC 0.00
- MYO 0.02
- Stochastic Oscillator
- ABVC 33.87
- MYO 18.15
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.
About MYO Myomo Inc.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).